AlphaHelix Molecular Diagnostics AB has appointed Peter Herte as its chief executive officer. The appointment will be effective from May 23, 2017. Prior to this appointment, Herte worked for Synsam as its marketing director. He has also worked with Nightingale Healthcare Communications, Grey Healthcare Europe London, Grey Healthcare Stockholm and Roche.